PHASE 1 RANDOMIZED STUDY OF THE STEADY-STATE (SS) EFFECTS OF BEMPEDOIC ACID (BA) ON THE SINGLE-DOSE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC) TABLETS IN HEALTHY FEMALES.

被引：0
|
作者：
Emery, M. [1 ]
MacDougall, D. [1 ]
Amore, B. [1 ]
McGonigal, J. [1 ]
Hanselman, J. [1 ]
Sasiela, W. [1 ]
机构：
[1] Esper Therapeut, Ann Arbor, MI USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-002
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 46 条
  • [21] A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT-P41 and reference denosumab in healthy males
    Kim, Anhye
    Hong, Jang Hee
    Shin, Wonsuk
    Yoo, Hyounggyoon
    Jung, Jin-Gyu
    Reginster, Jean-Yves
    Kim, Sunghyun
    Bae, Yunju
    Suh, Jeehye
    Kim, Sera
    Lee, Eunkyung
    Silverman, Stuart
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (07) : 655 - 663
  • [22] Pharmacodynamics and Pharmacokinetics of a Novel, Low-Dose, Soft-Gel Capsule of Acetylsalicylic Acid in Comparison with an Oral Solution After Single-Dose Administration to Healthy Volunteers: A Phase I, Two-Way Crossover Study
    Loprete, Luca
    Leuratti, Chiara
    Scarsi, Claudia
    Radicioni, Milko
    CLINICAL DRUG INVESTIGATION, 2014, 34 (01) : 19 - 25
  • [23] Pharmacodynamics and Pharmacokinetics of a Novel, Low-Dose, Soft-Gel Capsule of Acetylsalicylic Acid in Comparison with an Oral Solution After Single-Dose Administration to Healthy Volunteers: A Phase I, Two-Way Crossover Study
    Luca Loprete
    Chiara Leuratti
    Claudia Scarsi
    Milko Radicioni
    Clinical Drug Investigation, 2014, 34 : 19 - 25
  • [24] A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult Subjects
    Brager, Jenna
    Chapman, Chris
    Dunn, Leonard
    Kaplin, Adam
    DRUG RESEARCH, 2023, 73 (02) : 95 - 104
  • [25] A Phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults
    Swearingen, Dennis
    Pennick, Michael
    Shojaei, Amir
    Lyne, Andrew
    Fiske, Kimberly
    CLINICAL THERAPEUTICS, 2007, 29 (04) : 617 - 625
  • [26] A Pilot Phase 1, Randomized, Double-blind, Two-arm, Parallel Group, Single-dose Study to Evaluate the Safety and Pharmacokinetics of CT-P17 and Humira in Healthy Male Subjects
    Keystone, Edward
    Furst, Daniel
    Boyce, Malcolm
    van den Berg, Frans
    Lee, SangJoon
    Kim, SungHyun
    Bae, Yunju
    Yang, Goeun
    Koo, JuHeon
    Choi, EunJin
    Kay, Jonathan
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [27] Comparison of Effects of Two Different Formulations of Clopidogrel Bisulfate Tablets on Platelet Aggregation and Bleeding Time in Healthy Korean Volunteers: A Single-Dose, Randomized, Open-Label, 1-Week, Two-Period, Phase IV Crossover Study
    Shim, Chi Young
    Park, Sungha
    Song, Jae Woo
    Lee, Sang-Hak
    Kim, Jung-Sun
    Chung, Namsik
    CLINICAL THERAPEUTICS, 2010, 32 (09) : 1664 - 1673
  • [28] A Phase 1, Single-Center, Open-Label, Drug Interaction Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Co-Administered BPS-MR And Sildenafil At Steady-State In Healthy Subjects
    Armstrong, D. W., III
    Negro-Vilar, R. C.
    Di Marino, M. E.
    Staub, T.
    Wargin, W.
    Sullivan, E. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [29] A phase 1, randomized, placebo-controlled, single-and multiple-dose, double-blind study to evaluate the pharmacokinetics and safety of rimegepant orally disintegrating tablets 75 mg in healthy Chinese adults
    Li, Y.
    Bertz, R.
    Goodrich, R.
    HEADACHE, 2022, 62 (07): : 922 - 922
  • [30] Comparison of the Pharmacokinetics of Raltegravir Given at 2 Doses of 400 mg by Swallowing Versus One Dose of 800 mg by Chewing in Healthy Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Phase 1 Study
    Cattaneo, Dario
    Cossu, Maria V.
    Fucile, Serena
    Riva, Agostino
    Baldelli, Sara
    Meraviglia, Paola
    Landonio, Simona
    Impagnatiello, Caterina
    Resnati, Chiara
    Galli, Massimo
    Clementi, Emilio
    Capetti, Amedeo
    Rizzardini, Giuliano
    Gervasoni, Cristina
    THERAPEUTIC DRUG MONITORING, 2015, 37 (01) : 119 - 125
12345